Policy

The Medical Imaging & Technology Alliance (MITA) has issued a statement applauding the inclusion of text related to imaging technologies in the SUPPORT for Patients and Communities Act (HR 6), which President Trump signed into law on Wednesday, Oct. 24.

Molecular imaging societies have numerous recommendations for patients with diabetes who undergo fluoride-18 fluorodeoxyglucose (FDG) PET/CT tumor imaging. According to new research published in the Journal of the American College of Radiology, however, many providers are not explaining these things to patients when appointments are scheduled.

Breast density notification laws were designed to motivate supplemental breast cancer screening among women at an increased risk. However, they have resulted in more low-risk women undergoing unnecessary supplemental screening, according to new research published in the Journal of the American College of Radiology.

The Medical Imaging & Technology Alliance (MITA) has issued a statement in support of new research from the Pacific Research Institute (PRI) focused on issues with the medical device tax and why the PRI believes that tax should be repealed.

Beginning with services performed on Jan. 1, 2019, UnitedHealthcare will be reviewing the site of care for certain CT and MR imaging procedures to be performed in an outpatient hospital setting. Anthem implemented a similar policy in 2017.

The Medical Imaging & Technology Alliance (MITA) has issued a statement in support of the FDA’s recent efforts to strengthen its medical device cybersecurity program.

Patients with advanced breast cancer, along with their families and friends are planning a march on New Zealand’s Parliament to ask Pharmac, an area pharmaceutical company, to fund two drugs they say could potentially provide some relief.

U.K. Prime Minister Theresa May recently announced a new cancer strategy by implementing widespread rapid diagnostic centers across the country, in an effort to increase early detection and diagnosis, while improving cancer survival rates. But with a shortage of radiologists in the U.K., the question remains—is this possible?

California Gov. Jerry Brown has vetoed the state’s breast and ovarian cancer screening legislation, AB 2342.

The Medical Imaging & Technology Alliance (MITA) has issued a statement in support of the recently introduced Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018 (HR 6948).

The American College of Radiology (ACR) has released three new and nine revised topics to the ACR Appropriateness Criteria.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and American College of Nuclear Medicine (ACNM) have submitted a letter to CMS in response to the 2019 Hospital Outpatient Prospective Payment System (HOPPS) proposed rule, sharing both recommendations and concerns with the agency.